Oculis Holding AG
ICEX:OCS
Prices of ICEX stocks are not being updated. The latest OCS price on Alpha Spread is from May 28, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oculis Holding AG
ICEX:OCS
|
CH |
|
W
|
Weir Group PLC
DUS:42W
|
UK |
|
M
|
Minth Group Ltd
F:M3I
|
TW |
|
C
|
China Reinsurance (Group) Corp
F:C53
|
CN |
|
R
|
Ralph Lauren Corp
F:PRL
|
US |
|
Dexus
F:0DPS
|
AU |
|
La Francaise de l Energie SA
OTC:FDENF
|
FR |
|
H
|
Hochschild Mining PLC
F:H3M
|
UK |
|
C
|
CPL Group PCL
SET:CPL
|
TH |
|
C
|
China Everbright Ltd
XMUN:EVI
|
HK |
|
T
|
Tourism Holdings Ltd
ASX:THL
|
NZ |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
US |
Intrinsic Value
Is OCS undervalued or overvalued?
See the intrinsic value estimate for Oculis Holding AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Oculis Does
Oculis Holding AG is a biopharmaceutical company focused on eye and vision diseases. It develops medicines for conditions that damage the retina, the surface of the eye, and the optic nerve, aiming to deliver treatments that can be used more easily than traditional eye drugs. Its work is centered on clinical-stage drug development rather than running a broad commercial product business.
- Headquarters
- Switzerland CH
- Employees
- 60
- IPO date
- Mar 3, 2023
Earnings Waterfall
Oculis Holding AG
The intrinsic value for Oculis Holding AG (OCS) under the Base Case is hidden ISK.
Compared with the last price of 3 660 ISK on May 28, the stock appears hidden.